|
[1] PAPPACHAN JM, ANTONIO FA, EDAVALATH M, et al.Non-alcoholic fatty liver disease:a diabetologist's perspective[J].Endocrine, 2014, 45 (3) :344-353.
|
|
[2] GOH VJ, SILVER DL.The lipid droplet as a potential therapeutic target in NAFLD[J].Semin Liver Dis, 2013, 33 (4) :312-320.
|
|
[3] MIKOLASEVIC I, RACKI S, ZAPUTOVIC L, et al.Nonalcoholic fatty liver disease (NAFLD) :a new risk factor for adverse cardiovascular events in dialysis patients[J].Med Hypotheses, 2014, 82 (2) :205-208.
|
|
[4]HEBBARD L, GEORGE J.Animal models of nonalcoholic fatty liver disease[J].Nat Rev Gastroenterol Hepatol, 2011, 8 (1) :35-44.
|
|
[5]REDDY SK, ZHAN M, ALEXANDER HR, et al.Nonalcoholic fatty liver disease is associated with benign gastrointestinal disorders[J].World J Gastroenterol, 2013, 19 (45) :8301-8311.
|
|
[6]IMAJO K, YONEDA M, KESSOKU T, et al.Rodent models of nonalcoholic fatty liver disease/nonalcoholic steatohepatitis[J].Int J Mol Sci, 2013, 14 (11) :21833-21857.
|
|
[7]KANURI G, BERGHEIM I.In vitro and in vivo models of non-alcoholic fatty liver disease (NAFLD) [J].Int J Mol Sci, 2013, 14 (6) :11963-11980.
|
|
[8]GUEBRE-XABIER M, YANG S, LIN HZ, et al.Altered hepatic lymphocyte subpopulations in obesity-related murine fatty livers:potential mechanism for sensitization to liver damage[J].Hepatology, 2000, 31 (3) :633-640.
|
|
[9]LECLERCQ IA, FARRELL GC, FIELD J, et al.CYP2E1 and CYP4A as microsomal catalysts of lipid peroxides in murine nonalcoholic steatohepatitis[J].J Clin Invest, 2000, 105 (8) :1067-1075.
|
|
[10] KAPLAN LM.Leptin, obesity, and liver disease[J].Gastroenterology, 1998, 115 (4) :997-1001.
|
|
[11]SAHAI A, MALLADI P, PAN X, et al.Obese and diabetic db/db mice develop marked liver fibrosis in a model of nonalcoholic steatohepatitis:role of short-form leptin receptors and osteopontin[J].Am J Physiol Gastrointest Liver Physiol, 2004, 287 (5) :g1035-g1043.
|
|
[12]ZHANG DD, JIANG M, XIN YN, et al.Construction of lentivirus vectors containing PNPLA3 gene and overexpression of PNPLA3 in Huh-7 cells[J].Chin J Hepatol, 2013, 21 (3) :236-238. (in Chinese) 张丁丁, 姜曼, 辛永宁, 等.PNPLA3基因慢病毒载体及其过表达Huh-7细胞系的构建[J].中华肝脏病杂志, 2013, 21 (3) :236-238.
|
|
[13]ROTMAN Y, KOH C, ZMUDA JM, et al.The association of genetic variability in patatin-like phospholipase domain-containing protein 3 (PNPLA3) with histological severity of nonalcoholic fatty liver disease[J].Hepatology, 2010, 52 (3) :894-903.
|
|
[14] LI JZ, HUANG Y, KARAMAN R, et al.Chronic overexpression of PNPLA3I148M in mouse liver causes hepatic steatosis[J].J Clin Invest, 2012, 122 (11) :4130-4144.
|
|
[15]HAO Q, HANSEN JB, PETERSEN RK, et al.ADD1/SREBP1c activates the PGC1-alpha promoter in brown adipocytes[J].Biochim Biophys Acta, 2010, 1801 (4) :421-429.
|
|
[16]ESPENSHADE PJ.SREBPs:sterol-regulated transcription factors[J].J Cell Sci, 2006, 119 (Pt 6) :973-976.
|
|
[17] NAKAYAMA H, OTABE S, UENO T, et al.Transgenic mice expressing nuclear sterol regulatory element-binding protein 1c in adipose tissue exhibit liver histology similar to nonalcoholic steatohepatitis[J].Metabolism, 2007, 56 (4) :470-475.
|
|
[18]SHIMOMURA I, HAMMER RE, RICHARDSON JA, et al.Insulin resistance and diabetes mellitus in transgenic mice expressing nuclear SREBP-1c in adipose tissue:model for congenital generalized lipodystrophy[J].Genes Dev, 1998, 12 (20) :3182-3194.
|
|
[19]SCHATTENBERG JM, GALLE PR.Animal models of non-alcoholic steatohepatitis:of mice and man[J].Dig Dis, 2010, 28 (1) :247-254.
|
|
[20]MASAKI T, CHIBA S, TATSUKAWA H, et al.Adiponectin protects LPS-induced liver injury through modulation of TNF-alpha in KKAy obese mice[J].Hepatology, 2004, 40 (1) :177-184.
|
|
[21]MYERS MP, STOLAROV JP, ENG C, et al.P-TEN, the tumor suppressor from human chromosome 10q23, is a dual-specificity phosphatase[J].Proc Natl Acad Sci U S A, 1997, 94 (17) :9052-9057.
|
|
[22] HE L, HOU X, KANEL G, et al.The critical role of AKT2 in hepatic steatosis induced by PTEN loss[J].Am J Pathol, 2010, 176 (5) :2302-2308.
|
|
[23] SVEGLIATI-BARONI G, CANDELARESI C, SACCOMANNO S, et al.A model of insulin resistance and nonalcoholic steatohepatitis in rats:role of peroxisome proliferator-activated receptor-alpha and n-3 polyunsaturated fatty acid treatment on liver injury[J].Am J Pathol, 2006, 169 (3) :846-860.
|
|
[24]KERSTEN S, SEYDOUX J, PETERS JM, et al.Peroxisome proliferator-activated receptor alpha mediates the adaptive response to fasting[J].J Clin Invest, 1999, 103 (11) :1489-1498.
|
|
[25]REDDY JK.Nonalcoholic steatosis and steatohepatitis.Ⅲ.Peroxisomal beta-oxidation, PPAR alpha, and steatohepatitis[J].Am J Physiol Gastrointest Liver Physiol, 2001, 281 (6) :g1333-g1339.
|
|
[26] LONDON RM, GEORGE J.Pathogenesis of NASH:animal models[J].Clin Liver Dis, 2007, 11 (1) :55-74.
|
|
[27]LU SC, ALVAREZ L, HUANG ZZ, et al.Methionine adenosyltransferase 1A knockout mice are predisposed to liver injury and exhibit increased expression of genes involved in proliferation[J].Proc Natl Acad Sci U S A, 2001, 98 (10) :5560-5565.
|
|
[28] COOK WS, JAIN S, JIA Y, et al.Peroxisome proliferator-activated receptor alpha-responsive genes induced in the newborn but not prenatal liver of peroxisomal fatty acyl-CoA oxidase null mice[J].Exp Cell Res, 2001, 268 (1) :70-76.
|
|
[29]COBURN CT, KNAPP FJ, FEBBRAIO M, et al.Defective uptake and utilization of long chain fatty acids in muscle and adipose tissues of CD36 knockout mice[J].J Biol Chem, 2000, 275 (42) :32523-32529.
|
|
[30]MA KL, RUAN XZ, POWIS SH, et al.Inflammatory stress exacerbates lipid accumulation in hepatic cells and fatty livers of apolipoprotein E knockout mice[J].Hepatology, 2008, 48 (3) :770-781.
|
|
[31]TAKAHASHI Y, SOEJIMA Y, FUKUSATO T.Animal models of nonalcoholic fatty liver disease/nonalcoholic steatohepatitis[J].World J Gastroenterol, 2012, 18 (19) :2300-2308.
|
|
[32]DENG QG, SHE H, CHENG JH, et al.Steatohepatitis induced by intragastric overfeeding in mice[J].Hepatology, 2005, 42 (4) :905-914.
|
|
[33]ITO M, SUZUKI J, TSUJIOKA S, et al.Longitudinal analysis of murine steatohepatitis model induced by chronic exposure to highfat diet[J].Hepatol Res, 2007, 37 (1) :50-57.
|
|
[34] de ALWIS NM, DAY CP.Non-alcoholic fatty liver disease:the mist gradually clears[J].J Hepatol, 2008, 48 (Suppl 1) :s104-s112.
|
|
[35] ANSTEE QM, GOLDIN RD.Mouse models in non-alcoholic fatty liver disease and steatohepatitis research[J].Int J Exp Pathol, 2006, 87 (1) :1-16.
|
|
[36] DELA PA, LECLERCQ I, FIELD J, et al.NF-kappaB activation, rather than TNF, mediates hepatic inflammation in a murine dietary model of steatohepatitis[J].Gastroenterology, 2005, 129 (5) :1663-1674.
|
|
[37]LECLERCQ IA, FARRELL GC, FIELD J, et al.CYP2E1 and CYP4A as microsomal catalysts of lipid peroxides in murine nonalcoholic steatohepatitis[J].J Clin Invest, 2000, 105 (8) :1067-1075.
|
|
[38]IP E, FARRELL G, HALL P, et al.Administration of the potent PPARalpha agonist, Wy-14, 643, reverses nutritional fibrosis and steatohepatitis in mice[J].Hepatology, 2004, 39 (5) :1286-1296.
|
|
[39] LARTER CZ, YEH MM.Animal models of NASH:getting both pathology and metabolic context right[J].J Gastroenterol Hepatol, 2008, 23 (11) :1635-1648.
|
|
[40] KIRSCH R, CLARKSON V, SHEPHARD EG, et al.Rodent nutritional model of non-alcoholic steatohepatitis:species, strain and sex difference studies[J].J Gastroenterol Hepatol, 2003, 18 (11) :1272-1282.
|
|
[41] ACKERMAN Z, ORON-HERMAN M, GROZOVSKI M, et al.Fructose-induced fatty liver disease:hepatic effects of blood pressure and plasma triglyceride reduction[J].Hypertension, 2005, 45 (5) :1012-1018.
|
|
[42] ARMUTCU F, COSKUN O, GUREL A, et al.Thymosin alpha 1attenuates lipid peroxidation and improves fructose-induced steatohepatitis in rats[J].Clin Biochem, 2005, 38 (6) :540-547.
|
|
[43]KOHLI R, KIRBY M, XANTHAKOS SA, et al.High-fructose, medium chain trans fat diet induces liver fibrosis and elevates plasma coenzyme Q9 in a novel murine model of obesity and nonalcoholic steatohepatitis[J].Hepatology, 2010, 52 (3) :934-944.
|
|
[44]XING LX, HE YW.Experiment study on nonalcoholic fatty liver model induced by injection of oxytetracycline intraperitoneally in rats[J].J Clin Hepatol, 2007, 23 (1) :29-31. (in Chinese) 邢凌翔, 贺永文.氧四环素腹腔注射制备大鼠非酒精性脂肪肝模型的实验研究[J].临床肝胆病杂志, 2007, 23 (1) :29-31.
|
|
[45]WANG L, LYU JH, RAO WY, et al.Effect of baogan tablets on hepatic fibrosis induced by carbon tetrachloride complex factors in rats[J].Chin J Exp Med Formul, 2013, 19 (7) :234-236. (in Chinese) 王丽, 吕纪华, 饶伟源, 等.保肝片对大鼠肝纤维化模型的影响[J].中国实验方剂学杂志, 2013, 19 (7) :234-236.
|
|
[46] SINHA-HIKIM I, SINHA-HIKIM AP, SHEN R, et al.A novel cystine based antioxidant attenuates oxidative stress and hepatic steatosis in diet-induced obese mice[J].Exp Mol Pathol, 2011, 91 (1) :419-428.
|
|
[47] KASHIREDDY PV, RAO MS.Lack of peroxisome proliferator-activated receptor alpha in mice enhances methionine and choline deficient diet-induced steatohepatitis[J].Hepatol Res, 2004, 30 (2) :104-110.
|
|
[48]JU DH, ZHAO HY, LIU MJ.Advances in animal models of nonalcoholic fatty liver disease that combine disease and syndromes[J].World Chin J Dig, 2010, 18 (14) :1452-1455. (in Chinese) 鞠大宏, 赵宏艳, 刘梅洁.非酒精性脂肪性肝病病证结合动物模型的研究进展[J].世界华人消化杂志, 2010, 18 (14) :1452-1455.引证本文:HUANG HY, XIN YN, JIANG M, et al.Research advances in animal models of nonalcoholic fatty liver disease[J].J Clin Hepatol, 2014, 30 (9) :948-953. (in Chinese) 黄海燕, 辛永宁, 姜曼, 等.非酒精性脂肪性肝病动物实验模型研究进展[J].临床肝胆病杂志, 2014, 30 (9) :948-953.
|
DownLoad: